ABSTRACT Most of the current closed-loop deep brain stimulation (DBS) devices use a single biomarker in their feedback loop, which may limit their performance and applications. This paper presents the design, fabrication, and validation of a programmable multi-biomarker neural sensor which can be integrated into closed-loop DBS devices. The device is capable of sensing a combination of low-frequency (7-45 Hz), and high-frequency (200-1000 Hz) neural signals. The signals can be amplified with a digitally programmable gain within the range of 50-100 dB. The neural signals can be stored into a local memory for processing and validation. The sensing and storage functions are implemented via a combination of analog and digital circuits involving pre-amplifiers, filters, programmable post-amplifiers, microcontroller, digital potentiometer, and flash memory. The device is fabricated, and its performance is validated through: 1) bench tests using sinusoidal and pre-recorded neural signals; 2) in-vitro tests using pre-recorded neural signals in saline solution; and 3) in-vivo tests by recording neural signals from freely moving laboratory mice. The animals were implanted with a PlasticsOne electrode, and recording was conducted after recovery from the electrode implantation surgery. The experimental results are presented and discussed confirming the successful operation of the device. The size and weight of the device enable tetherless back-mountable use in pre-clinical trials.
I. INTRODUCTION
A recent review of the literature reveals that numerous efforts have been made to implement a feedback loop into conventional open-loop deep brain stimulation (DBS) platforms to produce closed-loop DBS devices [1] . Closed-loop DBS devices utilize neural recording circuitry that enables adaptive DBS via monitoring of neural signals as biomarkers of neurological disorders. Among different biomarkers, electrophysiological biomarkers are believed to convey desirable information for closing the feedback loop in DBS systems [2] .
Alpha band (8) (9) (10) (11) (12) (13) (14) Hz) activity of local field potentials (LFPs) is one of the potential electrophysiological biomarkers. The study by Neumann et al. [3] suggests that alpha-band activity in the limbic system could be a potential biomarker for the severity of symptoms in major depressive disorder. In this case, the closed-loop DBS device should suppress aberrant alpha-band activity [3] . Also, alpha-band activity is a biomarker of Parkinson's disease (PD). In PD, alpha-band power is maximal in the pedunculopontine nucleus (PPN) region, correlating with improved gait performance in PD [4] .
Beta band (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) Hz) activity of LFPs is also a biomarker of PD. It is decreased either by dopaminergic medication [5] or during electrical stimulation [6] . This reduction in the betaband oscillations is shown to be correlated with improvement of rigidity, akinesia and bradykinesia [7] , as well as freezing of gait [8] symptoms of PD. The correlation between beta-band activity and PD shows that closed-loop DBS should monitor beta-band activity from the sub-thalamic nucleus (STN) region as an effective biomarker [9] - [11] .
Slow-gamma band (sG: 30-45 Hz) activity of LFPs is a potential electrophysiological biomarker that a generic closed-loop DBS device should monitor. Maling et al. [12] showed that increased thalamic sG activity correlates with symptom relief following DBS in humans with Tourette's syndrome. In addition, suppression of the sG activity is shown to be linked with DBS-induced tremor symptom reduction in PD patients [13] . These findings have led to the hypothesis that sG-band activity of LFPs in the STN brain region should be monitored as an effective biomarker in closed-loop DBS devices.
The slow and fast high-frequency oscillation (HFO) bands (200-300 Hz and 300-400 Hz, respectively) of LFPs need to be monitored in closed-loop DBS devices. In humans, the HFO-band activity was observed in epilepsy [14] . In the epileptic brain, HFO-band activity is generated locally and appears frequently [15] , [16] . Zijlmans et al. [17] suggested HFO-band activity as a biomarker of epilepsy. In PD, the HFO-band activity was reported by Foffani et al. [18] . They showed that the 300-Hz rhythm is boosted either in dopaminergic medication or voluntary movements. They [18] , [19] concluded that DBS of the STN region could be enhanced by inducing HFO-band activity, which is absent in PD. López-Azcárate et al. [20] recorded LFPs from PD patients treated with STN-DBS. They observed that HFO-band amplitude was coupled with the beta phase in off-motor state. Apart from epilepsy and PD, the existence of HFO-band activity was also shown in the STN-LFPs of patients suffering from essential tremor and dystonia [21] . Özkurt et al. [22] identified a slow HFO (sHFO) and a fast HFO (fHFO) component in the range of 200-300 Hz and 300-400 Hz, respectively. They observed that the ratio of fHFO-and sHFO-band activity increases after levodopa intake, suggesting the STN-HFOband activity could be a neurophysiological biomarker of the dopaminergic and motor state in PD. Wang et al. [23] suggest that the correlation between HFO-band activity and akinesia could be used as a biomarker in closed-loop DBS. Also, HFOband activity allows a faster triggering of closed-loop DBS compared to beta-band activity [22] . These findings show the role of sHFO-and fHFO-band activity in control of several disorders.
Neural spike signals, may be also considered as a potential biomarker for use in closed-loop DBS devices. Neural spikes are pulsatile signals in the range of 100 Hz to 10 kHz, with most of the spike rates less than 1 kHz [24] . Specific changes in single unit neural spike firing rate may be representative of seizure occurrence in epilepsy patients [25] . Thus, treatment of epilepsy based on neural spikes as a biomarker may be achieved by closed-loop DBS devices.
Most of the current closed-loop DBS devices [24] , [26] - [35] use a single biomarker in their feedback loop which results in several issues: (i) the device may be used to detect only a limited number of symptoms of a neurological disorder. With one biomarker, on the other hand, some of the symptoms of a disorder may still remain undetected [9] , [36] , [37] ; (ii) the device may be used to detect only a limited number of neurological disorders that are characterized by the biomarker. Disorder that are not identified by the biomarker would not be detected; (iii) the device may not accurately detect a disease because the biomarker may be affected by the patient's dynamic physiological or psychological states [38] - [40] ; (iv) the detection accuracy of the biomarker may be reduced due to the device being affected by unexpected internal or external factors [41] - [43] . The use of multiple biomarkers may therefore increase the efficiency of the of the closed-loop DBS device. To tackle the stated issues, multi-biomarker neural sensors would be required.
In this paper, a digitally programmable multi-biomarker neural sensor is presented. This device is capable of recording alpha, beta, sG, sHFO, fHFO band activity from LFPs and neural spike signals within two channels. Its internal gain can be adjusted from 50 dB to 100 dB to measure neural signals ranging from 1 µV to over 1 mV. The device is low-cost, miniature in size and has a low weight suitable for backmountable use in pre-clinical trials with small laboratory animals. The device can be used in a closed-loop DBS setting, and offers some advantages over a number of existing neural sensors: (i) it can concurrently measure LFPs and spikes from a shared microelectrode, (ii) the recording configuration is user-selectable as single-ended and differential modes, and (iii) it has a wide range of programmable gain making it suitable for detection of a wide range of neural signals with varying amplitudes.
II. METHODOLOGY A. BIOMARKERS
The neural biomarkers exploration has mainly focused on spectral power extraction from oscillatory activity in physiologically significant frequency bands [29] . This oscillatory activity correlate with several diseases' symptoms. In this paper, a combination of several electrophysiological biomarkers from within LFPs and APs are sensed. These biomarkers include oscillatory activity in alpha, beta, sG, sHFO, and fHFO bands as well as neural spike signals, which are measured in two parallel channels from two shared electrode contacts. The oscillatory activity in alpha, beta, and sG bands are recorded in the first channel. The oscillatory activity in sHFO and fHFO bands, and neural spikes are measured in the second channel. Fig. 1 gives the details of channels and measured biomarkers. The reason for Postsuppressing the signals in the range of Hz is due to specific DBS requirements [44] , where the 130 Hz DBS artefact is rejected in the hardware instead of post-filtering in the software [44] . filtering techniques [45] degrade the signal quality because neural signal amplitudes are five to six times smaller than those of the stimulation artefact [44] . Fig. 2 shows the overall architecture for the two-channel neural sensor. The device comprises of analog and digital units. In the analog unit, there exist two parallel recording paths for signal conditioning of both low and high frequency signals. The neural signals at the electrodes are first preamplified to reach to a sufficient level before filtration. Then, the unwanted frequency components are suppressed through high-and low-pass analog filters. Subsequently, the neural signals are boosted with a programmable gain before digitization in the digital unit. In order to provide single-supply operation of amplifiers and filters, the negative components of the neural signals are shifted above the ground by means of a reference voltage generator. In the digital unit, there exists a microcontroller as the core of the device, which adjusts the gain of the analog unit, samples the neural data and writes them into a serial flash-memory, controls the LEDs, and also interacts with the user through push-buttons.
B. SYSTEM OVERVIEW

1) ELECTRODE AND ELECTRODE-DEVICE INTERFACE
An electrode by PlasticsOne Inc (Roanoke, VA-USA) (Fig. 3) , model MS303/2-B/SPC, is used in our in-vitro and in-vivo experiments. The electrode consists of two twisted and insulated stainless steel wires (0.2 mm bare electrode diameter, 0.23 mm insulated electrode diameter) connected to a pedestal.
To provide access from the electrode pedestal to the input of the device, a customized circular printed circuit board (PCB) was designed (see Fig. 3 ). It has two pins for inserting into the electrode pedestal base. The customized PCB is then connected to the main device via two lead wires and a connector. The length of the lead wires is set to 10 cm for a back-mountable electrode-device connection. 
2) ANALOG CIRCUIT
The neural signals are first obtained from the target brain region using the electrode (Fig. 4 (A) ). The device can record the neural signals in two different configurations: differential, and single-ended. The selection of the differential or the single-ended recording is done through an inputmode jumper connector (Fig. 4 (A) ). Leaving the connector open results in differential signal recording. In contrary, closing the connector using a jumper connector results in singleended recording by grounding one of the electrode contacts.
The analog circuit includes two channels: Ch1 as lowfrequency channel, and Ch2 as high-frequency channel. In this design, AD8232 chip manufactured by Analog Devices is used in the first stage of both channels, see Fig. 4 (B-C). The AD8232 chip is a good option for extraction, amplification, and filtration of small bio-potential signals in the presence of noisy conditions. This is because it consists of an instrumentation amplifier (IA), an operational amplifier (OA), a right leg drive amplifier (RLD), and a reference buffer, all together inside the chip that can reduce the PCB space and power consumption compared with traditional implementations. Each input of the PlasticsOne electrode is coupled with the internal IA (of AD8232) which is set to provide pre-amplification with a gain of 100 V/V while simultaneously implementing a single-pole high-pass filter (HPF) for filtering out the unwanted lower frequencies. The HPF cut-off frequency of Ch1 is implemented at 7 Hz though C2 and R3 components (this value is at 200 Hz for Ch2 though C6 and R8 components). The cutoff frequency of the HPF is given equation (1) .
In the current configuration, the RLD amplifier has been used to improve the common-mode rejection by maintaining the midscale voltage through R1 and R2 bias resistors (R6 and R7 in Ch2). The capacitor C1 (C5 in Ch2) between the RLDFB and RLD terminals creates an integrator. It has been included for common-mode line rejection of 50 Hz and its harmonies. The internal independent OA of AD8232 has been used to implement a two-pole low-pass filter (LPF) to remove additional high-frequency noise. For this purpose, the output of the IA from IAOUT terminal is connected to the input of the OA by means of a unity-gain Sallen-Key filter topology. The LPF cut-off frequency of Ch1 is at 45 Hz though R4, R5, C3, and C4 components (1 kHz for Ch2 through R9, R10, C7, and C8 components). As a common design procedure, we have set R4 = R5 and C3 = C4 (Ch2: R9 = R10 and C7 = C8), which results in the following relationship for LPF cutoff frequency:
AD8232 has a shutdown (SDN) control input terminal. In this application, we have permanently tied SDN to supply voltage (VCC) in order for circuit to always remain in the active mode. In addition, there is a fast restore (FR) control input terminal which reduces the duration of long settling tails for lower cut-off frequencies in the HPF. Because of the low cut-off frequency used in the HPF of CH1, neural signals may require several seconds to settle. This settling time can result in an unwanted delay after the electrode is connected. In order to avoid this long settling time, RF needs to be activated for Ch1 by permanently connecting the RF terminal to VCC. Because of the higher cut-off frequency used in the HPF of CH2, there is no need to use this mode and the RF terminal has been permanently tied to analog ground (AGND).
The last feature of the AD8232 chip is an embedded reference buffer, between the REFIN and REFOUT terminals, which simplifies the design of single-supply applications. This internal buffer is intended to create a virtual ground between the VCC and AGND. The signals present at the output of the IA are referenced to this voltage. Apart from creating an internal reference for IA, the buffer output voltage (accessed at REFOUT pin) is used as a reference in filtering. The reference voltage level is set at the buffer input terminal (REFIN pin) through a separate chip (Fig. 4 (D) ), MAX6023EBT12, which is a reference voltage generator. MAX6023EBT12 manufactured by MAXIM is a precision, low-dropout, micro-power voltage reference chip that converts the 3V VCC input voltage to the 1.25 V reference output voltage. This chip is very small in size and does not require any external compensation capacitor. The generated reference VOLUME 7, 2019 voltage (REF) derives the REFIN pin of AD8232 in both Ch1 and Ch2 circuits.
After pre-amplification and filtration, the signals at the output of AD8232 chip (defined as PreOut 1 and PreOut 2 for Ch1 and Ch2, respectively; see Fig. 4 (B) and (C)) are directed to the next stage ( Fig. 4 (E)) which is a programmable gain amplifier. In this stage, the programmability is attained by a combination of an OA with a digital potentiometer through a non-inverting amplifier topology. The generated reference voltage (REF) from the MAX6023 chip is consider to be a virtual ground for this stage. TSZ122, a dual version high precision zero drift micro-power chip, is used as OAs for both Ch1 and Ch2 signals. For each channel, a variable resistor is connected between the negative input and the output pins of the OA. A TPL0102 chip is employed as the digital potentiometer. It has two linear-taper digital potentiometers (A and B) with 256 wiper positions. Each variable resistor is used as a two-terminal rheostat between high and wiper terminals. The resistor values can change from 300 to 100 k . The gain achieved is given by equation (3).
where R v is the variable resistor and R f is the fixed resistor between the reference voltage and the negative input of OA (R12 in Ch1, and R14 in Ch2). The fixed resistor is set to 100 . Therefore, by substituting the low and high values of the variable resistor into the formula, it can be seen that the gain in this stage can be adjusted between 4 to 1001 V/V. Assuming the pre-amplifier stage gain to be fixed 100 V/V, the total variable gain of 400 -100100 V/V (∼ 50 -100 dB) is accessible using the current design. The digital potentiometer chip is controlled via the microcontroller in the digital part and is programmed using a physical bidirectional I2C interface involving the serial clock (SCL) and serial data (SDA) lines. Both SDA and SCL lines have been connected to VCC through pull-up resistors (R11 and R13). The unique device address given to the TPL0102 chip is 000 configured through A0 -A2 pins connected to AGND.
The amplified outputs of the final stage (identified as Ch1-Out and Ch2-Out) are directed to the microcontroller for digitization (see the next section). Two parallel capacitors (Fig. 4 (F) ) are used as bypass between the VCC and AGND lines in order to minimize the noise on the power supply traces. The capacitor network includes a 100 nF ceramic capacitor (C13) in parallel to a 470 µF tantalum capacitor (C12). The former is intended for decoupling the power supplies. The latter is necessary to maintain stability. Although the analog circuit is designed to consume micropower current range, the digital part including the microcontroller and the flash-memory drain reasonable amount of current from the battery when active. Therefore, to maintain stability of the circuit when sudden demand of current is needed, the use of C12 is unavoidable.
3) DIGITAL CIRCUIT
The main components of the digital circuit incudes a microcontroller (ATMEGA88PA), a serial flash-memory (AT45DB641E), LEDs, push-buttons, and communication port (see Fig. 5 (A) ). ATMEGA88PA is a high performance, low power 8-bit microcontroller. Its power consumption versus processing speed is optimizable via throughputs approaching 1 MIPS per MHz. In addition, it offers 16 KB of flash, 512 bytes of EEPROM, and 1 KB of internal SRAM. The chip supports C language compilers. The microcontroller does sampling and digitization of analog inputs (PC0 and PC2 pins) of Ch1 and Ch2 signals though the internal 10-bit ADC. The microcontroller also implements the programing of the digital potentiometer in the analog circuit using a physical bidirectional I2C interface involving the serial clock (SCL) and serial data (SDA) lines. Two LEDs are included into the device for recording (LED 1) and communication (LED 2) purposes. Each LED current is set via an external resistor (R15 and R16). In addition, two push-buttons are included in the device for user-device interaction purpose (Push-Button 1 for entering into the recording mode and Push-Button 2 for entering into the communication mode). In the recording mode, the device receives the analog data, digitizes and samples them, and then stores them on the serial flash-memory. In the communication mode, the device sends out data from the flash-memory using the embedded communication port. The microcontroller is programmed using P1 -P5 pads.
AT45DB641E is a 64-Mbit serial-interface sequential access flash-memory ideally suited for data storage applications. It operates from a single 1.7 -3.6 V VCC for the erase, program, and read operations. It is enabled through the Chip Select pin (CS) and accessed via a 3-wire interface consisting of the Serial Input (SI), Serial Output (SO), and the Serial Clock (SCK). All programming and erase cycles are selftimed in the AT45DB641E chip.
The AGND and digital ground (DGND) parts have been separated from each other via a very low ohm resistor ( Fig. 5 (B) ). This method helps keep the possible digital noise out of the analog circuit.
4) POWER SOURCE
The proposed device is a battery-operated system that can have its full functionality using a 2.5-3.5 V power source. A CR2032 coin battery (3V) has been used to supply power to both analog and digital circuits.
C. FABRICATION   Fig. 6 shows the fabricated neural sensor, manufactured on a two-layer PCB. As shown in Fig. 6 (A-B) , all the components are designed to sit on the top layer of the PCB. In addition, the device benefits from a circular configuration with 11 mm in radius and 8 mm in height (Fig. 6 (C-D) ), allowing the PCB to be hidden under a 3V CR2032 coin battery holder (Fig. 6 (E) ). As shown in Fig. 6 (F-G) , the total weight of the device including CR2032 coin battery and battery holder is 5.4 g, in which only 1.4 g is for the neural sensor itself. Being small and light-weight allow back-mountable configuration for use with large or small laboratory animals. As indicated in Fig. 6 (H) , there are two connector ports on the device, recording connector (R-Con) and communication connector (C-Con). The R-Con is for the electrode interface connection, and the C-Con is for connection to a computer. Moreover, two push-buttons are included on the device which are recording push-button (R-PB) and communication push-button (C-PB). The former is for starting/ stopping the data writing into the flash-memory, and the latter is for starting/stopping of the data serial communication with an external computer. The recording LED (R-LED) and communication LED (C-LED) on each side of the device shows the operation function of the device to the user. The input-mode connector (IM-Con) allows the user to define whether the recording is single-ended or differential. Leaving IM-Con open will cause the device to record in differential mode. The input mode is switched from differential to singleended via putting a small jumper connector that connects one electrode contacts to analog ground. Once the battery is placed into the device, the device enters the initialization mode in which the port pins, I^2 C and SPI buses, and the ADC are configured and the serial flash-memory is reset. In addition, the internal buffer is initialized and the digital potentiometer is programmed to a pre-specified gain of 78 dB.
Upon completion of the Initialization mode, both the LEDs blink to show that the device has entered into the Standby mode. In this mode, the ADC is disabled and both the pushbuttons (R-PB and C-PB) are iteratively checked until any push-button (PB) is pressed. Whichever the PB is pressed, the device enters the associated mode: R for Recording and C for Communication.
In the Recording mode, the ADC is enabled and the neural data is sensed, and then sampled from the Ch1 and Ch2 outputs. This data is continuously stored in the serial flash-memory locations. The indication of this mode is fast blinks of R-LED. The device remains in this mode until the R-PB is pressed for the second time. If R-PB is pressed, the device enters the Standby mode and waits for the next user command.
In the Communication mode, the ADC is disabled and the flash-memory locations are continuously read. In addition, the data is transmitted to an external computer via the C-Con port. The indication of this mode is fast blinking of C-LED.
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The device stays in this mode until the data is fully transferred or the user has pressed C-PB for the second time. In this case, the device returns to the Standby mode and for the next recording/communication command.
E. VALIDATIONS
The functionality of the proposed device has been validated through: (i) bench tests, (ii) in-vitro tests, and (iii) in-vivo tests. In the bench test validation, (i) sinusoidal and (ii) a pre-recorded neural signals are injected directly into the device inputs, and the outputs are compared with the original input signals. The in-vitro experiment has been conducted in saline solution which can simulate a neuron-electrode interface [46] . For this purpose, pre-recorded neural signals were injected into the saline solution and signals are then received by the electrode. The in-vivo test has been conducted on three 4 months old female mice. For this purpose, a single bipolar PlasticsOne electrode was implanted and subsequent, freelymoving recordings performed after recovery from surgery.
III. EXPERIMENTAL RESULTS
A. BENCH TESTS AND RESULTS
The bench tests include: (i) measurements of the device frequency response, (ii) application of sinusoidal, and (iii) application of pre-recorded neural signals to the input of the neural sensor (in a single-ended configuration) and analysing the device output. Fig. 8 illustrates the frequency response of both lowfrequency (Ch1, Fig. 8 (A) ) and high-frequency (Ch2, Fig. 8 (B) ) channels obtained by using the NI myDAQ system and it's bode plot software. The extracted data has been plotted in MATLAB software. The figure shows the minimum (∼50 dB), central (∼80 dB) and maximum (∼100 dB) gains accessible with the proposed device. It is worth mentioning that there are other 254 different programmable gain levels (linearly increasing) in between the minimum and maximum gain levels. The designed pass-band target is 7-45 Hz and 200-1000 Hz for Ch1 and Ch2, respectively (the red vertical lines show the target low and high cut-off frequencies). Due to the 0.1-10% tolerance of the resistors and capacitors used in the device, the real cut-off frequencies (−3 dB decrease from the maximum gain), have minor negligible deviations from their desired values.
1) FREQUENCY RESPONSE
2) BENCH TEST WITH SINUSOIDAL SIGNALS
Three sinusoidal signals (200 µVpp) with three different frequencies (25 Hz, 500 Hz, and 2000 Hz) were directly injected into the input of the neural sensor (programmed with a gain of 78 dB). The resulted analog outputs at low and highfrequency channels (Ch1 and Ch2) are presented in Fig. 9 . Because the 500 Hz and 2000 Hz frequencies are quite out of the Ch1 pass-band (> 40 dB), they have been totally filtered out in the outputs. Similarly, the 25 Hz and 2000 Hz signals have been reasonably attenuated in Ch2 due to being out of the Ch2 bandwidth. The reason for not being totally rejected is that these frequencies are approximately 15 dB lower than the maximum gain of Ch2. Therefore, they appear as an attenuated signal in the output. 
3) BENCH TEST WITH PRE-RECORDED NEURAL SIGNALS
The final bench test involved the application of pre-recorded neural signals to the input of the device. The pre-recorded neural signals have been supplied by Prof. Benoit Gosselin of Laval University, Canada. They were captured from hippocampus of a 23 g mouse. The data includes a range of lowand high-frequency components up to 6 kHz and pick-to pick amplitude of 400 µV, recorded with a sampling frequency of 20 kS/s. This signal was sent out to the device by the arbitrary waveform generator (ARB) software of the NI myDAQ system through its analog output AO-0 with an update rate of 2 kHz. The bench test results, including the pre-(input to the device) and post-(output from the device) amplification signals, have been shown in Fig. 10 (A) for the input, and Fig. 10 (B-C) for Ch1 and Ch2 outputs, respectively. The gain of the device in both Ch1 and Ch2 have been programmed at around 78 dB (central gain). The results shown in Fig. 10 are related to the first 500 ms (out of 450 s) of the data. Since the input signal contains a range of low and high-frequency components over the pass-band range of both Ch1 and Ch2, the filters have attenuated the undesirable components, and the outputs have correctly mimicked the input signal in both Ch1 and Ch2 
B. IN-VITRO TEST AND RESULTS
The in-vitro experiment has been conducted in saline solution that emulates the neuron-electrode interface [46] . The saline bath contains 0.9% NaCl per litter of distilled water. The setup used for the in-vitro saline-based experiment is presented in Fig. 11 . A copper wire (CW) is employed to deliver the pre-recorded neural signals into the saline bath. The PlasticsOne electrode contacts (EC1 and EC2) collects the signal propagated in the solution, and delivers it to the device for conditioning. The recording is done in the singleended configuration using the IM-CON option. The prerecorded neural signal is injected into the saline solution with an update rate of 2 kS/s. The device collected the signal, digitized it, and stored it on its internal flash-memory. Next, the data is extracted from the flash-memory, sent to an external computer via the C-CON, and then plotted in MATLAB software. Fig. 12 shows the plotted Ch1-Out and Ch2-Out signals. The digital circuit implements the sampling frequency of about 16 kHz. However, because the ADC takes one sample from each channel sequentially at a time, each channel is thus sampled with a sampling frequency of about 8 kHz. As shown in Fig. 12 , the Ch1 output follows the low-frequency variations of the input neural signal, while the Ch2 outputs retains the high-frequency variations of the signal. By comparison of these results (Fig. 12 (A) and (B) ) with their counterparts obtained from the bench test with pre-recorded neural signals (Fig. 10) , they seem to be compatible. The justification of the amplitude reduction is due to be the additional impedance in the signal path induced by the saline solution. This causes the attenuation of the signal before reaching the electrode. Nonetheless, it can be seen from Fig. 12 that the Ch1 and Ch2 outputs follow the low and high frequency fluctuations of the input signal.
C. IN-VIVO TEST AND RESULTS
For in-vivo validation, three 4 months old C57Bl/6 female mice were implanted with electrodes and subsequently, freely-moving recordings were performed after recovery from surgery. The general procedure for surgery has been previously described in [47] . Briefly, the mice were anesthetized with 2% isoflurane and placed in a supine position on a heating pad within a stereotaxic frame. A constant 2% isoflurane level was delivered throughout the surgery and adjusted according to each mouse's breathing rate. Depilatory cream was applied to the head to remove all hair at the surgical site. After sterilizing the skin with alcohol and betadine, a single incision was made from just behind the eyes to the most posterior part of the occipital bone (all tools, including scissors FST#14082-09, #55 forceps FST #11255-20, Dumont AA forceps FST #11210-10, drill head for Ideal Micro-Drill TM Surgical Drills #726065, drill bit FST#19007-05, were sterilized in a hot bead sterilizer VOLUME 7, 2019 before use). A small hole in the skull was drilled slightly posterior to the cranial suture. Carefully, a small skull screw (303 00-90 × 1/16 flat point stainless steel machine screw, B002SG89QQ) was screwed a few turns into the skull to serve as an anchor. The stereotaxic coordinates of Bregma were then used as a reference to locate three brain regions that are currently used as therapeutic targets for DBS: the dentate nucleus (cerebellum), medial globus pallidus (basal ganglia), and thalamus (ventral posterolateral nucleus). The coordinates as they relate to Bregma were shown in Table 1 . Next, a small 0.5 mm craniotomy was made and a single bipolar PlasticsOne electrode (#8IMS303T3B01, cut 3.5 mm below the pedestal; green arrow Fig. 13 (A) ) was lowered to the appropriate depth according to the target desired. After carefully drying the area with a sterile cotton swab, one round of Metabond (4 drops of B Quick Base For C&B METABOND R mixed with 1 drop of ''C'' Universal TBB Catalyst, mixed with Metabond Clear L-Powder) followed by a layer of dental cement was used to secure the scalp screw and the electrode in its position and to cover all exposed skull. A 1/2-1 inch long cannula (stainless steel tube) was glued onto the protruding electrode to later serve as a head mount (blue arrow Fig. 13 (A) ). This was secured with UV light epoxy and sealed with additional dental cement. Finally, 3M Vetbond (#NC0304169) was carefully applied around the border of dental cement and the mouse's fur to better ensure the implant's stability. The mice were provided with 0.75 mg/kg of buprenorphine (also provided pre-operatively) subcutaneously once a day for three days and allowed to recover post-surgery in a warmed incubator (V500, Peco Services Ltd., Cumbria, UK). In preparation for recording, the tetherless device was secured onto the back of a mouse (Fig. 13 (B) ), making certain to leave the recording button accessible. The electrodedevice interface was carefully plugged into the PlasticsOne electrode port by grasping the head mounted cannula for stability. After engaging the ''record'' button, the mouse was returned to its home cage and monitored for the entire duration of the neural recording session. All animal studies were performed under an approved IACUC protocol at Baylor College of Medicine. Fig. 14 shows the in-vivo results outputs from cerebellum, stored in the flash-memory of the neural sensor programmed with a gain of 70 dB. The presented signal in this figure represent a small portion of 8-minute recording of data. 
D. DBS INTERFERENCE
One of the major limitations of the closed-loop DBS approach is the appearance of a large stimulation artefact (typically 100-120 dB larger than the neural activity [26] ) on the neural recording path, making the simultaneous sensing and stimulation a challenge [48] . The neural recording circuit must be able to eliminate this large artefact from the weak neural signal in real-time for true biomarker measurements.
One of the techniques used to reject the stimulation artefact is the electrode configuration approach [48] . In this technique, the neural signals are sensed in a differential manner and the anode stimulation electrode is symmetrically placed between the recording electrodes [26] , [48] . As a result, the stimulation pulse interference acts as a common-mode signal which can be cancelled in the first stage instrumentation amplifier.
The performance of our neural sensor in cancelling the DBS has been tested in saline solution in two stages: (i) in the absence of neural source (Fig. 15 (A) ), and (ii) in the presence of neural source (Fig. 15 (B) ). The purpose of the first experiment is to examine the ability of the commonmode artefact cancellation of the neural sensor in reaction to the DBS pulses and in the absence of any neural signal source. The purpose of the second experiment is to examine the ability of the neural sensor in LFP source amplification in presence of a common-mode DBS artefact. 15 (C-F) shows the physical saline-based setup used to evaluate the DBS interference. A three-contact symmetric wire copper electrode (Fig. 15 (F) ) was used to represent the DBS lead. An open-loop DBS device was employed to generate the stimulation pulses with 200 µA current pulse amplitude, 130 Hz pulse frequency, and 90 µs pulse duration (as Fig. 16 (A) ).
The results obtained in the first experiment are shown in Fig. 16 (B) and (C) for the single-ended and differential recording configurations, respectively. In the single-ended recording configuration (measuring through one active electrode against the ground), the DBS pulses are not rejected, and appear as an amplified signal in the analog output of the neural sensor. However, using the differential recording configuration (measuring through two active electrodes), the DBS interference is attenuated around 24 dB in the output of the neural sensor compared to the single-ended recordings. The residual content of the stimulation pulse (as seen in Fig 16 (C) ) is related to the potential tolerance in the distance of the middle stimulation anode electrode from the two recording electrodes manufactured manually. A small difference in the distance between the recording and stimulation electrodes causes the common-mode signal to have a slightly higher amplitude in one recording electrode compared to the second one. This amplitude difference is then amplified in the differential recording circuits, hence producing the slight disturbance in the signal. The use of commercial DBS lead will alleviate this issue.
The results obtained by the second setup in response to the several neural sources are shown in Fig. 16 (D-G) . A sinusoidal signal with an amplitude of 1 mV is used to represent the neural signal source. The device is tested in response to four different frequencies 20 Hz, 260 Hz, 350 Hz, and 400 Hz as shown in Fig 16 (D)-(G) . For the 20 Hz neural source, in which the frequency is lower than the 130 Hz stimulation pulse, the low-frequency analog output shows the attenuated DBS interference appearing as a very small artefact summed with the amplified 20 Hz neural signal source. Despite this small disturbance, it is seen that the device can reasonably amplify the neural signal in presence of a large common-mode stimulation artefact. For the 260 Hz, 350 Hz and 400 Hz neural sources, where the frequencies are higher than the 130 Hz stimulation pulse, the high-frequency analog output shows the attenuated DBS interference appearing as a very small artefact in only specific periods (specified with red arrows in Fig 16 (E-G) ). For the 260 Hz input (twice of the 130 Hz DBS artefact), the stimulation disturbance appears once in every two periods, while for the 400 Hz input (∼ three times of the 130 Hz DBS artefact) the stimulation disturbance appears once in every three periods. It should be noted that the amplitude of this artefact is very small compared to the amplified signal, and thus cannot affect the biomarker extraction and control process in a closed-loop DBS device. In addition, the use of a real DBS lead may help to reduce this residual content because of the precise symmetry between the recording and stimulation electrodes.
IV. DISCUSSIONS
In our previous studies, we designed single [35] and multi-biomarker-based [49] neural sensors that have a fixed gain amplifier. However, this paper presents the design of a multi-biomarker (LFP and spikes) gain-programmable neural sensor, as well as its in-vivo validation. A comparison of the features of our device against those of some recent neural sensors [50] - [53] (within the last 3 years) is presented in Table 2 [50]- [54] .
This device has a wide programmable gain range compared to other examined devices [50] , [52] , [53] (having fixed or limited gain variability) that offers the following advantage. In LFPs, the magnitude of the potentials can vary from as low as 10 µV to over 1 mV [55] - [57] . This wide range depends on several factors including: (i) proportional contribution of the multiple current sources within the brain [58] , (ii) distance of the recording electrode from the current sources [58] , (iii) sign of the individual current sources [58] , (iv) different properties of the target brain tissue (e.g. resistivity and capacitance) [58] , [59] , (v) recording depth (cell type and the spatial distribution of synapses) [60] , (vi) electrode characteristics (type, effective surface area, and conductivity) [61] , (vii) subjects [58] - [60] , and (viii) disease occurrence or a change on the brain state (e.g. LFP level change by seizure occurrence in Epileptic patients [62] ). The LFP amplitude changing from 10 µV to 1 mV demands a neural sensor with a programmable gain that can change from at least 60 dB to 100 dB in order to amplify the varying potentials to at least 1 V. Therefore, the application of a fixed gain or limited-range programmable-gain neural sensor (see Table 2 ) will be quite limited. Our device has a programmable gain from 50 dB to 100 dB over the required range, which makes it a general-purpose neural sensor.
The proposed neural sensor is a battery-operated device working with voltages within the range 2.5 V to 3.5 V. These requirements led us to choose a 3V CR2032 coin battery (capacity: 240 mAh) for the operation of the device. The device can operate in four different modes (Initialization, Standby, Recording, and Communication) each consuming different current levels from the operated battery. The current consumption of the device in the Initialization, Standby, and Communication modes is about 3.3 mA. The current consumption increases to 14.35 mA in the Recording mode. While the device benefits from an onboard 64 Mbit flashmemory, the memory is included to store in-vivo brain signals for off-line processing and validation of the sensing function of the device. The memory feature might not however be required when the device is integrated into a closed-loop DBS system and on-line processings is required. Accordingly, the average operation time of the device on a CR2032 coin battery would be approximately 75 hours. This device has been designed using discrete components instead of the application-specific integrated circuits (ASIC) approach. While an ASIC is more compact in size, its design and development is very time consuming and expensive. Thus, the ASIC design approach is more suitable for humanbased applications rather than animal-based trials when lower costs and faster design process are important [63] Although our device has been designed based on discrete components, it benefits from a miniature physical size, and low weight. The board has a surface area of 5.1 cm2, volume: 4.08 cm3, and weight of 5.4 g including the coin battery and battery holder. The device can easily fit in a rat jacket to conduct back-mountable free-moving pre-clinical experiments with laboratory animals such as rats, pigs, etc. Although our device might not be the smallest available neural sensing system, it is very low-cost, and can sense both at single-ended and differential modes, has a wide-range programmable gain. The proposed device dioe snot offer a wireless data transfer feature. Adding a wireless module, such as a bluetooth low energy (BLE) device, will increase the power consumption, weight, and size of the device.
Finally, the performance of the proposed device was validated via: (i) bench tests though direct connection of sinusoidal and pre-recorded signals to the input of the device, (ii) in-vitro testl in saline solution, and (iii) in-vivo test on three 4 months old female mice. In addition, the performance of the neural sensor in cancelling the DBS artefact is also tested in saline solution in two stages: (i) in the absence of neural source, and (ii) in the presence of neural source. The device successfully passed these experiments, and it is ready to be used in a closed-loop DBS platform. This device senses, amplifies and filters two specific frequency bands comprising six biomarkers (alpha, beta, slow gamma, slow high-frequency oscillations, fast high-frequency oscillations, and spikes). A feature extraction algorithm and a control strategy will be deployed into the microcontroller to create closed-loop operation. The computing capability of the microcontroller is suitable for implementation of simple VOLUME 7, 2019 feature extraction and control algorithms in an iterative manner in the closed-loop DBS setting. However, the use of a more advanced microcontroller is suggested if more complex processing is required where the overall power consumption of the device in not a concern.
V. CONCLUSION
In this paper, a neural sensor was presented which is capable of simultaneously measuring LFPs and spikes, digitizing the measured signals, storing them into an on-board flashmemory, and transferring them to an external computer. The device is a programmable, miniature (radius: 11 mm), lightweight (5.6 g including battery), tetherless, and selfcontained. The performance of the device was validated through bench tests (using sinusoidal and pre-recorded neural signals), in-vitro test (using saline solution as a simulator of brain environment), and in-vivo test (brain of three female mice) tests. The results obtained through these tests indicate the successful neural sensing performance. Two further experimens were conducted to study the role of the DBS intereference. The results show the attenuation of the DBS artefact to around 24 dB through the differential compared to the single-ended recording configuration. The results confirm the device suitability for the future integration into a closedloop DBS system. 
